We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.

Delisted

INFI was delisted on the 13th of September, 2023.

68 hedge funds and large institutions have $13.9M invested in Infinity Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

434% more call options, than puts

Call options by funds: $155K | Put options by funds: $29K

11% less funds holding

Funds holding: 7668 (-8)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

47% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 19

55% less capital invested

Capital invested by funds: $30.8M → $13.9M (-$16.9M)

Holders
68
Holders Change
-8
Holders Change %
-10.53%
% of All Funds
1.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
10
Reduced
19
Closed
18
Calls
$155K
Puts
$29K
Net Calls
+$126K
Net Calls Change
-$245K
Name Holding Trade Value Shares
Change
Change in
Stake
HSBC Holdings
76
HSBC Holdings
United Kingdom
-$18K -15,241 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
-$16K -13,691 Closed
AWM
78
AE Wealth Management
Kansas
-$16K -13,559 Closed
Dimensional Fund Advisors
79
Dimensional Fund Advisors
Texas
-$16K -13,057 Closed
Wolverine Trading
80
Wolverine Trading
Illinois
-$10.1K -11,895 Closed
Man Group
81
Man Group
United Kingdom
-$13K -11,025 Closed
CUAMC
82
China Universal Asset Management Company
China
-$1K -836 Closed
Royal Bank of Canada
83
Royal Bank of Canada
Ontario, Canada
+$31 +36 +4%
Carson Wealth (CWM LLC)
84
Carson Wealth (CWM LLC)
Nebraska
+$275 +323 New

INFI Hedge Fund Activity: Q4 2022 in Review

68 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q4 2022, worth a combined $13.9M — down 55% from $30.8M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of INFI and 12 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 10 added.

The largest buyer was Mariner, opening a new position worth an estimated $1.03M. The largest seller was Polar Capital Holdings, cutting an estimated $2.49M.

  • 68 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q4 2022, down from 76 in Q3 2022.
  • Funds reported $13.9M of Infinity Pharmaceuticals, Inc. stock for Q4 2022, down 55% quarter-over-quarter.
  • 12 funds opened new Infinity Pharmaceuticals, Inc. positions in Q4 2022 and 18 closed out, a net change of -6 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q4 2022 was Mariner, an estimated $1.03M added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q4 2022 was Polar Capital Holdings, an estimated $2.49M sold.

Based on aggregated 13F filings for Q4 2022.